HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $2.8 million in its fourth quarter.
The Holliston, Massachusetts-based company said it had a loss of 6 cents per share. Earnings, adjusted for one-time gains and costs, came to less than 1 cent on a per-share basis.
The medical instruments maker posted revenue of $23.7 million in the period.
For the year, the company reported a loss of $56.7 million, or $1.28 per share. Revenue was reported as $86.6 million.
For the current quarter ending in March, Harvard Bioscience said it expects revenue in the range of $20 million to $22 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HBIO at https://www.zacks.com/ap/HBIO
/Server%20racks%20by%20dotshock%20via%20Shutterstock.jpg)
/Amazon%20-%20Image%20by%20bluestork%20via%20Shutterstock.jpg)
/Apple%20logo%20-%20by%20Pexels%20via%20Pixabay.jpg)